Company intelligence / Profile preview

Phytronix Technologies

Quebec City, Quebec, Canadaphytronix.com ↗

Ownership: Private
Development stage: Commercial

Overview

Phytronix Technologies commercializes the Luxon Ion Source®, a second-generation device based on its patented LDTD® technology. This enables ultra-high-throughput mass spectrometry analysis in under four seconds per sample and has been adopted for pharmaceutical, toxicology, clinical, and environmental/food applications. The company does not develop therapeutics or diagnostics directly but provides enabling technologies for high-throughput laboratory analysis. No clinical results are applicable as it does not run therapeutic programs.

Modalities: Device (analytical instrumentation)
Industry: Drug Discovery Services

Partnerships

MEDTEQ+SciexThermo Fisher ScientificWaters CorporationShimadzu

Beyond the preview

Go deeper on Phytronix Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phytronix Technologies.

Explore the full profile